Yahoo Web Search

Search results

  1. Emergent BioSolutions Inc. (EBS) 4.7600 -0.1800 (-3.64%) At close: May 24 at 4:00 PM EDT. 4.8800 +0.12 (+2.52%) After hours: May 24 at 7:58 PM EDT. 1D. 5D. 3M. 6M. YTD. 1Y. 5Y. All. Key...

    • Conversations

      Find the latest Emergent BioSolutions Inc. (EBS) stock...

    • Financials

      Get the detailed quarterly/annual income statement for...

    • Profile

      See the company profile for Emergent BioSolutions Inc. (EBS)...

    • Statistics

      Find out all the key statistics for Emergent BioSolutions...

    • Options

      View the basic EBS option chain and compare options of...

    • Analysis

      See Emergent BioSolutions Inc. (EBS) stock analyst...

  2. 1,600. Get the latest Emergent Biosolutions Inc (EBS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

  3. 3 days ago · Merck & Co. Inc. -1.22%. $332.03B. EBS | Complete Emergent Biosolutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  4. People also ask

  5. May 1, 2024 · Get the latest data and insights on Emergent Biosolutions, Inc. Common Stock (EBS), a biotechnology company that develops and manufactures medical countermeasures. See bid, ask, volume, 52 week range, earnings, dividends, and more.

  6. 3 days ago · Get the latest information on EBS stock, including price, quote, news, analysis, and financials. See the company's performance, outlook, and challenges in the biodefense and opioid crisis markets.

    • EBS Stock1
    • EBS Stock2
    • EBS Stock3
    • EBS Stock4
    • EBS Stock5
  7. Get the latest information on EBS stock, including price, performance, ratings, forecasts and historical data. Emergent BioSolutions is a biopharmaceutical company that develops and manufactures vaccines and therapies for public health emergencies.

  8. View the latest Emergent Biosolutions Inc. (EBS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

  1. People also search for